Project Details
Description
Preclinical Studies in Pluripotent Stem Cell-Derived Myogenic Progenitors to Enable a First-in-Human Phase 1 Safety/Dose Escalation Trial for Duchenne Muscular Dystrophy
| Status | Active |
|---|---|
| Effective start/end date | 9/15/19 → 7/31/23 |
Funding
- DUCHENNE UK
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.